OTC CONCEPTS LIMITED

Active Ashford

Manufacture of pharmaceutical preparations

0 employees website.com
Manufacture of pharmaceutical preparations
O

OTC CONCEPTS LIMITED

Manufacture of pharmaceutical preparations

Founded 28 Oct 2002 Active Ashford, England 0 employees website.com
Manufacture of pharmaceutical preparations
Accounts Submitted 26 Jan 2026 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 27 Oct 2025 Next due 8 Nov 2026 5 months remaining
Net assets £-1K £0 2024 year on year
Total assets £0
Total Liabilities £1K £0 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

2nd Floor, Connect 38 1 Dover Place Ashford Kent TN23 1FB England

Full company profile for OTC CONCEPTS LIMITED (04574659), an active company based in Ashford, England. Incorporated 28 Oct 2002. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type audit-exemption-subsidiary
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

-£1.00k

Total Liabilities

£1.00k

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Terry John PetersenDirectorBritishEngland5215 Jul 2024Active

Shareholders

Shareholders (1)

Kent Pharma Uk Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Kent Pharma Uk Limited

United Kingdom

Active
Notified 25 Jun 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Ian John Kirk

Ceased 25 Jun 2021

Ceased

Peter Noel Miller Cox

Ceased 25 Jun 2021

Ceased

Group Structure

Group Structure

DUKE STREET LLP united kingdom
DUKE STREET V LIMITED united kingdom
KENT PHARMA UK LIMITED united kingdom
OTC CONCEPTS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Jan 2026AccountsAnnual accounts made up to 31 Mar 2025
26 Jan 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/03/25
26 Jan 2026AccountsAnnual accounts filed
8 Jan 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/03/25
8 Jan 2026AccountsAnnual accounts filed
26 Jan 2026 Accounts

Annual accounts made up to 31 Mar 2025

26 Jan 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/03/25

26 Jan 2026 Accounts

Annual accounts filed

8 Jan 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

8 Jan 2026 Accounts

Annual accounts filed

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

4 months ago on 26 Jan 2026

Audit exemption statement of guarantee by parent company for period ending 31/03/25

4 months ago on 26 Jan 2026

Annual accounts filed

4 months ago on 26 Jan 2026

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

5 months ago on 8 Jan 2026

Annual accounts filed

5 months ago on 8 Jan 2026